摘要
嘌呤ATP有著名的监管作用,中枢神经系统功能和病理对胶质细胞由于其操作——小胶质细胞,星形胶质细胞和少突胶质细胞。ATP作为显然无处不在的“gliotransmitter”所发布的星形胶质细胞和其他细胞嘌呤受体激活邻近细胞。在病理学,ATP的释放中转组织损伤和修复由其直接作用于神经胶质细胞完整性和生存。ATP在神经胶质的行为是通过广泛的受体介导,大致分为ionotropic P2X和metabotropic(g蛋白耦合受体(GPCR))P2Y受体,其中有多个亚型(P2X1-P2X7和P2Y1-P2Y14)。ATP-mediated星形胶质细胞和小胶质细胞之间的相互作用在中枢神经系统的免疫反应的中心,突出角色P2X4,P2X7,P2Y1,P2Y6 P2Y12受体亚型。少突胶质细胞,P2X7 P2Y1受体亚型分别由两部分构成的函数在调停少突细胞破坏和保护。嘌呤受体调节胶质病理学,突出角色在缺血、神经炎症,多个Scelerosis、神经性疼痛和创伤性损伤。值得注意的是,神经胶质ATP信号可能与衰老和改变与髓鞘形成障碍和免疫在阿尔茨海默氏症。因此,胶质嘌呤受体在多种神经病理学提供潜在的治疗靶点,但Jeckyll和海德嘌呤信号的本质突显出进一步的研究的重要性,全面了解角色不同嘌呤受体在介导的组织损伤和修复。
关键词: 神经胶质. 星形胶质细胞. 少突胶质细胞.ATP. 嘌呤受体
图形摘要
Current Drug Targets
Title:A Central Role for ATP Signalling in Glial Interactions in the CNS
Volume: 17 Issue: 16
Author(s): Andrea Rivera, Ilaria Vanzulli, Arthur M. Butt
Affiliation:
关键词: 神经胶质. 星形胶质细胞. 少突胶质细胞.ATP. 嘌呤受体
摘要: The purine ATP has a prominent regulatory role in CNS function and pathology due to its actions on glial cells - microglia, astrocytes and oligodendrocytes. ATP serves as an apparently ubiquitous ‘gliotransmitter’ that is released by astrocytes and other cells to activate purine receptors on neighbouring cells. In pathology, the release of ATP mediates both tissue damage and repair by its direct effects on glial cell integrity and survival. The actions of ATP on glia are mediated via a wide range of receptors, broadly divided into ionotropic P2X and metabotropic (G-protein coupled receptors (GPCR)) P2Y receptors, of which there are multiple subtypes (P2X1-P2X7 and P2Y1-P2Y14). ATP-mediated interactions between astrocytes and microglia are at the centre of immune responses in the CNS, with prominent roles for the P2X4, P2X7, P2Y1, P2Y6 and P2Y12 receptor subtypes. In oligodendrocytes, P2X7 and P2Y1 receptor subtypes have a bipartite function in respectively mediating oligodendrocyte destruction and protection. Purine receptors mediate glial pathology, with prominent roles in ischemia, neuroinflammation, Multiple Scelerosis, neuropathic pain and traumatic injury. Notably, glial ATP signalling may be altered with ageing and is implicated in impaired myelination and immunity in Alzheimer’s disease. Hence, glial purine receptors provide potential therapeutic targets in multiple neuropathologies, but the ‘Jeckyll and Hyde’ nature of purine signalling underscores the importance of further research and a comprehensive understanding of the roles of the different purine receptors in mediating tissue damage and repair.
Export Options
About this article
Cite this article as:
Andrea Rivera, Ilaria Vanzulli, Arthur M. Butt , A Central Role for ATP Signalling in Glial Interactions in the CNS, Current Drug Targets 2016; 17 (16) . https://dx.doi.org/10.2174/1389450117666160711154529
DOI https://dx.doi.org/10.2174/1389450117666160711154529 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preface [Hot Topic: Current Status of Neuroprotection in Traumatic Brain Injury (Executive Editors: Maria Mataro and Juan Sahuquillo)]
Current Pharmaceutical Design Cytoskeletal Pathologies of Age-Related Diseases between Elderly Sri Lankan (Colombo) and Indian (Bangalore) Brain Samples
Current Alzheimer Research Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research Proinflammatory Cytokines and Chemokines in Neonatal Brain Damage
Current Pediatric Reviews Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Current Aging Science Cardiomyopathy of Pregnancy
Current Women`s Health Reviews Crystallography of Membrane Proteins, Major Targets in Drug Design
Mini-Reviews in Medicinal Chemistry Targeting Role of Glioma Stem Cells for Glioblastoma Multiforme
Current Medicinal Chemistry Astrocytic Expression of the Immunoreceptor CD300f Protects Hippocampal Neurons from Amyloid-β Oligomer Toxicity In Vitro
Current Alzheimer Research Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design Green Tea, A Medicinal Food with Promising Neurological Benefits
Current Neuropharmacology Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer's Disease
Current Alzheimer Research Photodynamic Therapy For Non-Melanoma Skin Cancers
Current Cancer Therapy Reviews May Exercise Prevent Addiction?
Current Neuropharmacology Cannabinoids: Occurrence and Medicinal Chemistry
Current Medicinal Chemistry Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-κB Connection
Current Topics in Medicinal Chemistry Neural Stem Cell Transplantation and CNS Diseases
CNS & Neurological Disorders - Drug Targets A Novel Botulinum Toxin TAT-EGFP-HCS Fusion Protein Capable of Specific Delivery Through the Blood-brain Barrier to the Central Nervous System
CNS & Neurological Disorders - Drug Targets Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) – Lesson from Adjudin
Current Medicinal Chemistry